跳至主要内容
临床试验/ACTRN12614000008628
ACTRN12614000008628招募中3 期

A double-blind, randomised, placebo-controlled study to evaluate the effectiveness of an orally dosed supplement, Skin Accumax, containing vitamin A, vitamin E, vitamin C, phosphatidylcholine (lecithin) and diindolylmethane, on treating acne in men and women aged between 16 and 35.

Integrated Health Group Pty. Ltd.0 个研究点目标入组 80 人开始时间: 2014年1月3日最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
16 Years 至 35 Years(—)
性别
All

入选标准

  • Males and females
  • Aged between 16 and 35
  • Have persistent acne grade II and III
  • Currently using standard anti-microbial washes as the skin treatment only
  • Otherwise healthy
  • Written informed consent from the subject and/or guardians (under 18 years)

排除标准

  • Any condition which in the opinion of the investigator makes the subject unsuitable for inclusion
  • Males or females receiving treatment for acne (including corticosteroids, estrogens, progesterone) within the last month
  • Females currently on the contraceptive pill, pregnant or breastfeeding
  • Any person currently on anti-coagulant therapy.
  • Participation in any other clinical trial during last 30 days
  • Simultaneous participation in another clinical trial

研究者

发起方
Integrated Health Group Pty. Ltd.

相似试验

已完成
3 期
A double-blind, randomised, placebo-controlled study to evaluate the effect of orally-dosed LipiSperse curcumin and/or palmitoylethanolamide (PEA) on exercise recovery in healthy males.Exercise recoveryAlternative and Complementary Medicine - Herbal remedies
ACTRN12618000285257RDC Global Pty Ltd42
已完成
不适用
A double-blind, randomised, placebo-controlled study to evaluate the effect of an orally-dosed herbal formulation containing Testofen, on sexual function, performance, and serum testosterone levels in healthy males.Sexual performanceSexual functionAlternative and Complementary Medicine - Herbal remediesMetabolic and Endocrine - Other metabolic disorders
ACTRN12611000830998AZPA International60
进行中(未招募)
1 期
Clinical trial to assess the effect of SNF472 on progression of build up of calcium in coronary blood vessels in patients with kidney disease.
EUCTR2016-002834-59-ESaboratoris Sanifit450
进行中(未招募)
1 期
Clinical trial to assess the effect of SNF472 on progression of build up of calcium in coronary blood vessels in patients with kidney disease.Cardiovascular calcification in blood vessels in end-stage-renal-disease (ESRD) patients on haemodialysis (HD).MedDRA version: 20.1 Level: LLT Classification code 10014646 Term: End stage renal disease (ESRD) System Organ Class: 100000004857MedDRA version: 20.0 Level: PT Classification code 10051753 Term: Vascular calcification System Organ Class: 10047065 - Vascular disordersMedDRA version: 20.0 Level: PT Classification code 10018875 Term: Haemodialysis System Organ Class: 10042613 - Surgical and medical procedures
EUCTR2016-002834-59-GBSanifit Therapeutics S.A.270
已完成
2 期
A study looking at the effectiveness of a oral herbal supplement for helping to manage the symptoms of enlarged prostateBenign Prostatic HypertrophyAlternative and Complementary Medicine - Herbal remediesRenal and Urogenital - Other renal and urogenital disorders
ACTRN12610000168055Totally Natural Products68